KUMAMOTO University

R

研究実績RESEARCH ACHIEVEMENTS

  1. Oda K, Jono H, Nosaka K and Saito H.

    Reduced nephrotoxicity with vancomycin therapeutic drug monitoring guided by area under the concentration-time curve against a trough 15-20 μg/mL concentration.

    Int J Antimicrob Agents 56: 106109,2020. doi: 10.1016/j.ijantimicag.2020.106109.

    https://pubmed.ncbi.nlm.nih.gov/32721597/

     

  2. Matsumura T, Nakamura-Ishizu A, Muddineni SSNA, Tan DQ, Wang CO, Tokunaga K,Tirado-Magallanes R, Sian S, Benoukraf T, Okuda T, Asou N, Matsuoka M, Osato M, Suda T.

    Hematopoietic stem cells acquire survival advantage by loss of RUNX1 methylation identified in familial leukemia.

    Blood 136:1919-1932,2020. doi: 10.1182/blood.2019004292.

    https://pubmed.ncbi.nlm.nih.gov/32573733/

     

  3. Kusumoto S, Tanaka Y, Suzuki R, Watanabe T, Nakata M, Sakai R, Fukushima N, Fukushima T, Moriuchi Y, Itoh K, Nosaka K, Choi I, Sawa M, Okamoto R, Tsujimura H, Uchida T, Suzuki S, Okamoto M, Takahashi T, Sugiura I, Onishi Y, Kohri M, Yoshida S, Kojima M, Takahashi H, Tomita A, Atsuta Y, Maruyama D, Tanaka E, Suzuki T, Kinoshita T, Ogura M, Ueda R and Mizokami M.

    Ultra-high sensitivity HBsAg assay can diagnose HBV reactivation following rituximab-based therapy in patients with lymphoma.

    J Hepatol 73(2):285-293,2020.  doi: 10.1016/j.jhep.2020.03.009. Epub 2020 Mar 17.

    https://pubmed.ncbi.nlm.nih.gov/32194183/

     

  4. Fuji S, Kurosawa S, Inamoto Y, Murata T, Utsunomiya A, Uchimaru K, Yamasaki S, Inoue Y, Moriuchi Y, Choi I, Ogata M, Hidaka M, Yamaguchi T, Fukuda T.

    A decision analysis comparing unrelated bone marrow transplantation and cord blood transplantation in patients with aggressive adult T-cell leukemia-lymphoma.

    Int J Hematol 111(3):427-433,2020. doi: 10.1007/s12185-019-02777-w. Epub 2019 Nov 7.

    https://pubmed.ncbi.nlm.nih.gov/31701480/

     

  5. Imaizumi Y, Iwanaga M, Nosaka K, Ishitsuka K, Ishizawa K, Ito S, Amano M, Ishida T, Uike N, Utsunomiya A, Ohshima K, Tanaka J, Tokura Y, Tobinai K, Watanabe T, Uchimaru K and Tsukasaki K for collaborative Investigators.

    Prognosis of patients with adult T-cell leukemia/lymphoma in Japan: A nationwide hospital-based study.

    Cancer Sci 111(12): 4567-4580. doi: 10.1111/cas.14658. Epub 2020 Oct 21.

    https://pubmed.ncbi.nlm.nih.gov/32976684/

     

  6. Yonekura K, Kusumoto S, Choi I, Nakano N, Ito A, Suehiro Y, Imaizumi Y, Yoshimitsu M, Nosaka K, Ohtsuka E, Hidaka M, Jo T. Sasaki H, Moriuchi Y, Ogata M, Tatetsu H, Ishitsuka K, Miyazaki Y, Ueda R, Utsunomiya A, Ishida T.

    Mogamulizumab for adult T-cell leukemia-lymphoma: a multicenter prospective observational study.

    Blood A dv 4(20):5133-5145,2020. doi: 10.1182/bloodadvances. 2020003053.

    https://pubmed.ncbi.nlm.nih.gov/33091125/

     

  7. Nishimura N, Endo S, Kawano Y.

    Myeloma Mouse Models in Studying Myeloma Associated Bone Disease.

    Encyclopedia of Bone Biology 3:355-361,2020.

     

     

     

  8. Nakamura T, Nakamura T, Amano M, Miyakawa T, Yamagata Y, Matsuoka M, Nakata H.
    A Conformational Escape Reaction of HIV-1 against an Allosteric Integrase Inhibitor.
    J Virol. 2020 Sep 15;94(19):e00486-20. doi: 10.1128/JVI.00486-20. PMID: 32611758; PMCID: PMC7495394

  9. Kuriyama H, Fukushima S, Nakahara S, Kanemaru H, Miyashita A, Aoi J, Tomita Y, Kawasaki T, Nosaka K and Ihn H.

    Serious disseminated intravascular coagulation associated with combination therapy of nivolumab and ipilimumab in advanced melanoma.

    J Dermatol 47(6):e235-e237,2020. doi: 10.1111/1346-8138.15336. Epub 2020 Apr 10.

    https://pubmed.ncbi.nlm.nih.gov/32275077/

     

  10. Yanagawa Y, Shimogawara R, Endo T, Fukushima R, Gatanaga H, Hayasaka K, Kikuchi Y, Kobayashi T, Koga M, Koibuchi T, Miyagawa T, Nagata A, Nakata H, Oka S, Otsuka R, Sakai K, Shibuya M, Shingyochi H, Tsuchihashi E, Watanabe K, Yagita K.

    Utility of the Rapid Antigen Detection Test E. histolytica Quik Chek for the Diagnosis of Entamoeba histolytica Infection in Nonendemic Situations.

    J Clin Microbiol 58(11):e01991-20,2020. doi: 10.1128/JCM.01991-20. Print 2020 Oct 21.

    https://pubmed.ncbi.nlm.nih.gov/32878955/

     

  11. Matsumura T, Nakamura-Ishizu A, Muddineni SSNA, Tan DQ, Wang CQ, Tokunaga K, Tirado-Magallanes R, Sian S, Benoukraf T, Okuda T, Asou N, Matsuoka M, Osato M, Suda T

    Hematopoietic stem cells acquire survival advantage by loss of RUNX1 methylation identified in familial leukemia.

    Blood 136(17):1919-1932,2020. doi: 10.1182/blood.2019004292.

    https://pubmed.ncbi.nlm.nih.gov/32573733/

     

  12. Oda K, Miyakawa T, Katanoda T, Hashiguchi Y, Iwamura K, Nosaka K, Yamaguchi A, Jono H and Saito H.

    A case of recovery from aphasia following dose reduction of cefepime by bayesian prediction-based therapeutic drug monitoring.

    J Infect Chemother 26(5):498-501,2020. doi: 10.1016/j.jiac.2019.10.006. Epub 2020 Mar 4.

    https://pubmed.ncbi.nlm.nih.gov/32143960/

     

  13. Sakata K, Yasuoka H, Yoshimoto K, Takeuchi T.

    Refractory IgG4-related Pleural Disease with Chylothorax: A Case Report and Literature Review.

    Intern Med Online ahead of print,2021.  doi: 10.1093/rheumatology/keaa312.

    https://pubmed.ncbi.nlm.nih.gov/32743653/

     

  14. Ghosh AK, Kovela S, Osswald HL, Amano M, Aoki M, Agniswamy J, Wang YF, Weber IT, Mitsuya H.
    Structure-Based Design of Highly Potent HIV-1 Protease Inhibitors Containing New Tricyclic Ring P2-Ligands: Design, Synthesis, Biological, and X-ray Structural Studies.
    J Med Chem. 2020 May 14;63(9):4867-4879. doi: 10.1021/acs.jmedchem.0c00202. PMID: 32348139; PMCID: PMC7425579

  15. Oda K, Katonoda T, Hashiguchi Y, Kondo S, Narita Y, Iwamura K, Nosaka K, Jono H and Saito H.

    Development and evaluation of a vancomycin dosing nomogram to achieve the target area under the concentration-time curve. A retrospective study.

    J Infect Chemother 26(5):444-450,2020. doi: 10.1016/j.jiac.2019.11.009. Epub 2019 Dec 24.

    https://pubmed.ncbi.nlm.nih.gov/31879186/

     

  16. Kondo Y, Suzuki K, Inoue Y, Sakata K, Takahashi C, Kaneko Y, Takeuchi T.

    Safety and tolerability of ultrasound-guided synovial needle biopsy in Japanese arthritis patients.

    Mod Rheumatol Online ahead of print. 20:1-9,2020. doi: 10.1080/14397595.2020.1847754.

    https://pubmed.ncbi.nlm.nih.gov/33155872/

     

     

  17. Higuchi Y, Yasunaga JI, Mitagami Y, Tsukamoto H, Nakashima K, Ohshima K, Matsuoka M.

    HTLV-1 induces T cell malignancy and inflammation by viral antisense factor-mediated modulation of the cytokine signaling.

    Proc Natl Acad Sci U S A. 2020 Jun 16;117(24):13740-13749. doi: 10.1073/pnas.1922884117. Epub 2020 May 29.

    https://pubmed.ncbi.nlm.nih.gov/32471947/

     

     

  18. Okuma K, Kuramitsu M, Niwa T, Taniguchi T, Masaki Y, Ueda G, Matsumoto C, Sobata R, Sagara Y, Nakamura H, Satake M, Miura K, Fuchi N, Masuzaki H, Okayama A, Umeki K, Yamano Y, Sato T, Iwanaga M, Uchimaru K, Nakashima M, Utsunomiya A, Kubota R, Ishitsuka K, Hasegawa H, Sasaki D, Koh KR, Taki M, Nosaka K, Ogata M, Naruse I, Kaneko N, Okajima S, Tezuka K, Ikebe E, Matsuoka S, Itabashi K, Saito S, Watanabe T and Hamaguchi I

    Establishment of a novel diagnostic test algorithm for human T-cell leukemia virus type 1 infection with line immunoassay replacement of western blotting: a collaborative study for performance evaluation of diagnostic assays in Japan.

    Retrovirology 17(1):26, 2020. doi: 10.1186/s12977-020-00534-0.

    https://pubmed.ncbi.nlm.nih.gov/32831150/

     

     

  19. Utsunomiya M, Dobashi H, Odani T, Saito K, Yokogawa N, Nagasaka K, Takenaka K, Soejima M, Sugihara T, Hagiyama H,Hirata S, Matsui K, Nonomura Y, Kondo M, Suzuki F, Nawata Y, Tomita M, Kihara M, Yokoyama-Kokuryo W, Hirano F, Yamazaki H, Sakai R, Nanki T, Koike R, Miyasaka N, Harigai M.

    An open-label, randomized controlled trial of sulfamethoxazole-trimethoprim for Pneumocystis prophylaxis: results of 52-week follow-up.

    Rheumatol Adv Pract 4(2):rkaa029,2020.  doi: 10.1093/rap/rkaa029. eCollection 2020

    https://pubmed.ncbi.nlm.nih.gov/33134810/

     

     

  20. Kimura Y, Iwanaga E, Iwanaga K, Endo S, Inoue Y, Tokunaga K, Nagahata Y, Masuda K, Kawamoto H, Matsuoka M.

    A regulatory element in the 3′-untranslated region of CEBPA is associated with myeloid/NK/T-cell leukemia.

    Eur J Haematol. 2020 Nov 16.doi:10.1111/ejh.13551. PMID:33197296

    https://pubmed.ncbi.nlm.nih.gov/33197296/

     

  21. Makita S, Maruyama D, Maeshima AM, Taniguchi H, Yuda S, Toyoda K, Yamauchi N, Fukuhara S, Munakata W, Kobayashi Y, Kurihara H, Izutsu K and Tobinai K.

    A comparison of clinical staging using the Lugano versus Ann Arbor classifications in Japanese patients with Hodgkin lymphoma.

    Asia Pac J Clin Oncol 16(3):108-114,2020.  doi: 10.1111/ajco.13248. Epub 2019 Dec 4.

    https://pubmed.ncbi.nlm.nih.gov/31802636/

     

  22. Maeda M, Tanabe-Shibuya J, Miyazato P, Masutani H, Yasunaga JI, Usami K, Shimizu A, Matsuoka M.

    IL-2/IL-2 Receptor Pathway Plays a Crucial Role in the Growth and Malignant Transformation of HTLV-1-Infected T Cells to Develop Adult T-Cell Leukemia.

    Front Microbiol. 2020 Mar 6;11:356. doi: 10.3389/fmicb.2020.00356. eCollection 2020.

    https://pubmed.ncbi.nlm.nih.gov/32210945/

     

  23. Shichijo T, Fuji S, Nagler A, Bazarbachi A, Mohty M, Savani BN.

    Personalizing rabbit anti-thymocyte globulin therapy for prevention of graft-versus-host disease after allogeneic hematopoietic cell transplantation: is there an optimal dose?

    Bone Marrow Transplant 55(3): 505-522,2020.doi: 10.1038/s41409-019-0643-9. Epub 2019 Aug 21.

    https://pubmed.ncbi.nlm.nih.gov/31435032/

     

  24. Cui G, Shimba A, Ma G, Takahara K, Tani-Ichi S, Zhu Y, Asahi T, Abe A, Miyachi H, Kitano S, Hara T, Yasunaga JI, Suwanai H, Yamada H, Matsuoka M, Ueki K, Yoshikai Y, Ikuta K.

    IL-7R-Dependent Phosphatidylinositol 3-Kinase Competes with the STAT5 Signal to Modulate T Cell Development and Homeostasis.

    J Immunol. 2020 Feb 15;204(4):844-857. doi: 10.4049/jimmunol.1900456. Epub 2020 Jan 10.

    https://pubmed.ncbi.nlm.nih.gov/31924648/

     

CONTACT US

C

  • 患者様へ

    外来診療の方は外来予約センターより
    ご予約をお願いいたします。
    外来予約センター

  • 学生・研修医・医療関係者の方へ

    TEL
    096-373-5156
    FAX
    096-373-5158
    Mail
    nikyo@kumamoto-u.ac.jp
Copyright 2019 KUMAMOTO University HRI All Rights Reserved.